HH-3806

N/A

Report date: 2023/12/22 16:11:36
NME

Base Information

Drug NameHH-3806
Drug Alias NameHH-3806HH3806
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 2 inhibitors
TargetsBromodomain-containing protein 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator CompaniesShangHai HaiHe Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTigermed Australia Pty LtdShangHai HaiHe Biopharma Co Ltd
Inactive CompaniesHaihe Biopharma (HK) Ltd
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A